Poehling Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,143
Closed -$2K 195
2018
Q2
$2K Hold
1,143
﹤0.01% 275
2018
Q1
$3K Hold
1,143
﹤0.01% 270
2017
Q4
$2K Buy
+1,143
New +$2K ﹤0.01% 259